Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Giovanni Caffarena"'
Autor:
Ilaria Righi, Ivan Barone, Lorenzo Rosso, Letizia Corinna Morlacchi, Valeria Rossetti, Giovanni Caffarena, Fiona Limanaqi, Alessandro Palleschi, Mario Clerici, Daria Trabattoni
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Lung transplantation offers a lifesaving option for patients with end-stage lung disease, but it is marred by a high risk of post-transplant infections, particularly involving multidrug-resistant bacteria, Cytomegalovirus, and fungal pathogens. This
Externí odkaz:
https://doaj.org/article/7779a1e79c8c457e9116a6f47c0a77c5
Autor:
Alessandro Baisi, Alessandra Mazzucco, Giovanni Caffarena, Gerardo Cioffi, Angelo Guttadauro, Ugo Cioffi
Publikováno v:
Frontiers in Surgery, Vol 8 (2021)
Background: SARS-CoV-2 is a new disease with some manifestations not yet well-known. Sharing experiences in this topic is crucial for the optimal management of the patients.Case Presentation: Left upper extremity deep vein thrombosis (UEDVT) due to a
Externí odkaz:
https://doaj.org/article/b9503102e261456da43743db2bd0e282
Autor:
Giorgio Alberto Croci, Lorenzo Rosso, S. Pieropan, Shehab Mohamed, Giovanni Caffarena, Davide Tosi, Andrea Cara
Publikováno v:
OBM Transplantation. 4
Pulmonary transplantation (LuTx) is established as a treatment option for patients with end-stage lung diseases, such as chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung disease, and pulmonary arterial hypertension. Acute rej
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1d6e2fae3698c4154a02642364c1594
https://doi.org/10.21926/obm.transplant.2004129
https://doi.org/10.21926/obm.transplant.2004129